These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 27509411)

  • 1. Primary cutaneous CD30(+) lymphoproliferative disorders.
    Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
    J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycosis Fungoides Associated With Lesions in the Spectrum of Primary Cutaneous CD30+ Lymphoproliferative Disorders: The Same Process or 3 Coexisting Lymphomas?
    Cieza-Díaz DE; Prieto-Torres L; Rodríguez-Pinilla SM; Córdoba Mascuñano R; Manso Alonso R; Machan S; Piris Pinilla MÁ; Requena Caballero L
    Am J Dermatopathol; 2019 Nov; 41(11):846-850. PubMed ID: 30946099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin.
    de la Garza Bravo MM; Patel KP; Loghavi S; Curry JL; Torres Cabala CA; Cason RC; Gangar P; Prieto VG; Medeiros LJ; Duvic M; Tetzlaff MT
    Hum Pathol; 2015 Apr; 46(4):558-69. PubMed ID: 25666664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma.
    Gill RPK; Gantchev J; Martínez Villarreal A; Ramchatesingh B; Netchiporouk E; Akilov OE; Ødum N; Gniadecki R; Koralov SB; Litvinov IV
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical Management of CD30⁺ Lymphoproliferative Disorders.
    Hughey LC
    Dermatol Clin; 2015 Oct; 33(4):819-33. PubMed ID: 26433852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides.
    Mitteldorf C; Robson A; Tronnier M; Pfaltz MC; Kempf W
    Dermatology; 2015; 231(2):164-70. PubMed ID: 26111483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review.
    Di Raimondo C; Parekh V; Song JY; Rosen ST; Querfeld C; Zain J; Martinez XU; Abdulla FR
    Curr Hematol Malig Rep; 2020 Aug; 15(4):333-342. PubMed ID: 32435988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary cutaneous lymphoma-a case series of 163 patients].
    Nashan D; Friedrich CM; Geissler E; Schmitt-Graeff A; Klein F; Meiss F
    Hautarzt; 2018 Dec; 69(12):1014-1020. PubMed ID: 29881891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.
    DeCoteau JF; Butmarc JR; Kinney MC; Kadin ME
    Blood; 1996 Apr; 87(8):3437-41. PubMed ID: 8605362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.
    Kempf W
    Semin Diagn Pathol; 2017 Jan; 34(1):22-35. PubMed ID: 27993440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.
    Kempf W; Levi E; Kamarashev J; Kutzner H; Pfeifer W; Petrogiannis-Haliotis T; Burg G; Kadin ME
    J Cutan Pathol; 2002 May; 29(5):295-300. PubMed ID: 12100631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized lymphomatoid papulosis: Unilesional lymphomatoid papulosis, regional lymphomatoid papulosis, and persistent agmination of lymphomatoid papulosis.
    Magro CM; Mo JH; Telang G
    Clin Dermatol; 2022; 40(6):622-638. PubMed ID: 35907581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8-positive lymphomatoid papulosis (type D): Some lesions may lack CD30 expression and overlap histologically with mycosis fungoides.
    Simo OC; Warren SJ; Mark L; Hoffmann K; Alomari AK
    Int J Dermatol; 2019 Jul; 58(7):800-805. PubMed ID: 30520526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients.
    Wieser I; Oh CW; Talpur R; Duvic M
    J Am Acad Dermatol; 2016 Jan; 74(1):59-67. PubMed ID: 26518172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.
    Marschalkó M; Gyöngyösi N; Noll J; Károlyi Z; Wikonkál N; Hársing J; Kuroli E; Csomor J; Matolcsy A; Sarolta K; Szepesi Á
    J Cutan Pathol; 2016 Nov; 43(11):963-973. PubMed ID: 27461449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD30-positive lymphoproliferative disorders-An Australian Clinical Practice Statement from the Peter MacCallum Cancer Centre.
    Bhabha FK; McCormack C; Campbell BA; Lade S; Buelens O; Van Der Weyden C; Prince HM
    Australas J Dermatol; 2023 May; 64(2):194-203. PubMed ID: 36892928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders.
    Liang X; Smoller BR; Golitz LE
    J Cutan Pathol; 2002 Sep; 29(8):459-64. PubMed ID: 12207739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature.
    Stowman AM; Hsia LL; Kanner WA; Mahadevan MS; Bullock GC; Patterson JW
    Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.
    Trager MH; Chen C; Husain S; Geskin LJ
    J Dermatol; 2020 May; 47(5):546-550. PubMed ID: 32100361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.